Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorLoma Linda University

About this trial

This investigator-initiated, open-label, randomized controlled trial will explore the effects of two treatment arms, comparing standard treatment with normal saline against Irrisept, a jet lavage solution containing a low concentration of Chlorhexidine Gluconate (CHG) at 0.05% in 99.95% sterile water for irrigation. The study aims to evaluate the impact on postoperative wound healing in patients who have undergone cesarean delivery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18 or older

Singleton pregnancy

Planned cesarean delivery at gestational age 37 weeks or later at Loma Linda University Children's Hospital

Planned post-operative follow up with Loma Linda OBGYN

Disqualifiers

Emergency cesarean delivery

Trial design

Design model

Parallel

Treatments tested in this trial

  • Irrisept

    Device

    450ml low concentration (0.05%) Chlorhexidine Gluconate (CHG) in 99.95% Sterile Water

  • Normal Saline

    Drug

    450mL

Treatment groups

400 Participants
are divided into 2 treatment groups
Group A: IrriseptExperimental treatment 1 intervention
Group B: Normal SalineActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Composite wound evaluation scale after caesarean delivery

Wound Evaluation scale will be used to evaluate appropriate healing in the following categories: redness, bruising, discharge, tissue breakdown, wound infection

Time frame
Up to 8 weeks postop

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Loma Linda University

Lead sponsor

Irrimax Corporation

Collaborator